Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Assets Average (2016 - 2026)

Ekso Bionics Holdings has reported Assets Average over the past 13 years, most recently at $20.9 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 25.22% to $20.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.9 million, a 25.22% decrease, with the full-year FY2025 number at $23.4 million, down 15.85% from a year prior.
  • Assets Average reached $20.9 million in Q4 2025 per EKSO's latest filing, down from $22.4 million in the prior quarter.
  • The five-year high for Assets Average was $54.7 million in Q2 2021, with the low at $20.9 million in Q4 2025.
  • The 5-year median for Assets Average is $34.1 million (2023), against an average of $35.5 million.
  • Peak YoY movement for Assets Average: soared 126.62% in 2021, then fell 25.81% in 2024.
  • Tracing EKSO's Assets Average over 5 years: stood at $49.9 million in 2021, then fell by 19.7% to $40.1 million in 2022, then dropped by 25.07% to $30.1 million in 2023, then decreased by 7.05% to $27.9 million in 2024, then dropped by 25.22% to $20.9 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $20.9 million, $22.4 million, and $25.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.